While COVID-19 cases have decreased or remained stable nationally over the past few months, experts expect the number of cases to rise in the fall and winter. The National Advisory Committee on Immunization (NACI) has said there will be updated…
Immune discusses the current understanding of immune memory to SARS-CoV-2 infection and COVID-19 vaccines, which supersedes that of any other acute infectious disease. Show notes at https://www.microbe.tv/immune/immune-66 Become a patron of Immune at microbe.tv/contribute ——————————— CONNECT ——————————— 🎯 Subscribe! https://bit.ly/2HOYdNP…
In COVID-19 clinical update #122, Dr. Griffin discusses vaccine availability and coverage among children, post-infection health impairments in children and adolescents, infection detection using salvia and nasopharyngeal samples, effectiveness of vaccines during delta dominance, durability of vaccine against severe outcomes,…
In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EUA for boosters in 5-11 year olds, B.1.1.529 attack rate, scent dogs, Omicron and pets, Paxlovid, Veklury, Fluvoxamine, antigen positivity after isolation, inflammasome activation and severe disease, and…
Guardian Australia’s medical editor Melissa Davey looks at the difference between the immunity to Covid-19 that comes from vaccinations and boosters and that which comes naturally after recovering from infection. Overall, viewing Omicron infection as a ‘natural booster’ which makes a third vaccine dose…
In COVID-19 clinical update #98, Daniel Griffin reviews COVID-19 in South Africa, recognition of Omicron by ancestral T cells, booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression to severe disease, management of hospitalized…
